Jinhua Zhang is the founder of IASO Biotherapeutics. IASO Biotherapeutics has raised $120M in total funding. Latest round: Series B.
Jinhua Zhang established IASO Biotherapeutics in March 2017 and serves as the company's Chairman and Chief Executive Officer. She has led the company through multiple financing rounds and advanced its BCMA CAR-T therapy CT103A into a Phase 2 Pivotal trial.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide